Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
Rchr
J-GLOBAL ID：201901007206264152
Update date: Feb. 25, 2025 Tadashi Ikegami
イケガミ タダシ | Tadashi Ikegami
- 2023 - 2027 Mechanism of sarcopenia development mediated by skeletal muscle bile acid receptors using a mouse model with human-like bile acid composition
- 2022 - 2025 胆汁酸ヒト化マウスを用いたNAFL/NASH/HCC進展メカニズムの解明
- 2020 - 2024 肝硬変患者における骨格筋代償能の血液生化学的評価法の開発
- 2019 - 2023 Development of evaluation method for the three major nutrient utilization state during exercise using saliva sample
- 2017 - 2020 Production and phenotype analysis of mouse models with humanized bile acid composition
Show all
- Hiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, et al. Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease. Hepatology communications. 2025. 9. 1
- Hajime Ueda, Akira Honda, Teruo Miyazaki, Yukio Morishita, Takeshi Hirayama, Junichi Iwamoto, Tadashi Ikegami. High-fat/high-sucrose diet results in a high rate of MASH with HCC in a mouse model of human-like bile acid composition. Hepatology communications. 2025. 9. 1
- Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Koichi Takaguchi, Makoto Nakamuta, Tsunamasa Watanabe, Asahiro Morishita, Joji Tani, Hironao Okubo, et al. ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis. Journal of gastroenterology. 2024. 59. 8. 709-718
- Taeang Arai, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, et al. Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2024. 22. 4. 789-797
- Masaya Sato, Masatoshi Akamatsu, Toshihide Shima, Tadashi Ikegami, Mikio Yanase, Shintaro Mikami, Jun Imamura, Takuma Nakatsuka, Ryosuke Tateishi, Naoko Yamauchi, et al. Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial. The American journal of gastroenterology. 2023. 118. 8. 1365-1372
- 岩本 淳一, 門馬 匡邦, 玉虫 惇, 上田 元, 中川 俊一郎, 森山 由貴, 小西 直樹, 屋良 昭一郎, 宮崎 照雄, 平山 剛, et al. 長期経口摂取困難例および炎症性腸疾患でのカルニチン欠乏に関する検討. 消化と吸収. 2024. 47. 1. 53-53
- 門馬 匡邦, 岩本 淳一, 玉虫 惇, 上田 元, 小西 直樹, 屋良 昭一郎, 宮崎 照雄, 池上 正, 本多 彰. 血中胆汁酸分析を用いたdysbiosisの評価. 消化と吸収. 2024. 46. 2. 155-158
- 中川 俊一郎, 岩本 淳一, 高木 亮輔, 森山 由貴, 柿崎 文郎, 玉虫 惇, 門馬 匡邦, 小西 直樹, 屋良 昭一郎, 平山 剛, et al. 免疫チェックポイント阻害剤投与後に発症した小腸炎の一例. Progress of Digestive Endoscopy. 2024. 104. 1. 93-94
- 宮崎 照雄, 池上 正, 本多 彰. 肝疾患と臓器相関(胆汁酸,Microbiome含む) 硬化性胆管炎の発症に対する疎水性胆汁酸の影響. 肝臓. 2024. 65. Suppl.1. A192-A192
- 上田 元, 本多 彰, 池上 正. 脂肪性肝疾患 胆汁酸ヒト化マウスを用いたMASH/HCCモデルにおける肝発癌メカニズム. 肝臓. 2024. 65. Suppl.1. A214-A214
-
HCV screening strategies for the general population in Japan
(Taiwan International Conference for HCV elimination 2024) -
HCV screening strategies for the general population in Japan
(The HCV Policy Forum at 33 rd Anuual Meeing of APASL 2024)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
